WallStreetZenWallStreetZen

NASDAQ: CLPT
Clearpoint Neuro Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CLPT

Based on 1 analyst offering 12 month price targets for Clearpoint Neuro Inc

Min Forecast
$20.00+121.48%
Avg Forecast
$20.00+121.48%
Max Forecast
$20.00+121.48%

Should I buy or sell CLPT stock?

Based on 1 analyst offering ratings for Clearpoint Neuro Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CLPT's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CLPT as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their CLPT stock forecasts and price targets.

CLPT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-18

1 of 1

Forecast return on equity

Is CLPT forecast to generate an efficient return?

Company
-66.95%
Industry
20.41%
Market
149.82%
CLPT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CLPT forecast to generate an efficient return on assets?

Company
-19.19%
Industry
11.83%
CLPT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CLPT earnings per share forecast

What is CLPT's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.82
Avg 2 year Forecast
-$0.63

CLPT revenue forecast

What is CLPT's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$54.9M+48.43%
Avg 2 year Forecast
$67.5M+82.64%
Avg 3 year Forecast
$161.6M+337.02%
CLPT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CLPT revenue growth forecast

How is CLPT forecast to perform vs Medical Devices companies and vs the US market?

Company
19.71%
Industry
9.7%
Market
25.01%
CLPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CLPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CLPT vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
CLPT$9.03$20.00+121.48%Strong Buy
RXST$6.44$10.00+55.28%Hold
SENS$6.48$14.17+118.63%Buy
TLSI$3.93$7.00+78.12%Strong Buy
SI$14.30$21.67+51.52%Strong Buy
View Top Medical Device Stocks

Clearpoint Neuro Stock Forecast FAQ

Is Clearpoint Neuro Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CLPT) stock is to Strong Buy CLPT stock.

Out of 1 analyst, 1 (100%) are recommending CLPT as a Strong Buy, 0 (0%) are recommending CLPT as a Buy, 0 (0%) are recommending CLPT as a Hold, 0 (0%) are recommending CLPT as a Sell, and 0 (0%) are recommending CLPT as a Strong Sell.

If you're new to stock investing, here's how to buy Clearpoint Neuro stock.

What is CLPT's earnings growth forecast for 2026-2027?

(NASDAQ: CLPT) Clearpoint Neuro's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 57.75%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,670.09%.

Clearpoint Neuro's earnings in 2026 is -$25,540,000.On average, 4 Wall Street analysts forecast CLPT's earnings for 2026 to be -$24,357,008, with the lowest CLPT earnings forecast at -$25,000,714, and the highest CLPT earnings forecast at -$23,360,302.

In 2027, CLPT is forecast to generate -$18,759,435 in earnings, with the lowest earnings forecast at -$18,023,770 and the highest earnings forecast at -$19,311,183.

What is CLPT's revenue growth forecast for 2026-2030?

(NASDAQ: CLPT) Clearpoint Neuro's forecast annual revenue growth rate of 19.71% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.01%.

Clearpoint Neuro's revenue in 2026 is $36,971,000.On average, 4 Wall Street analysts forecast CLPT's revenue for 2026 to be $1,627,834,805, with the lowest CLPT revenue forecast at $1,558,184,026, and the highest CLPT revenue forecast at $1,681,941,713. On average, 3 Wall Street analysts forecast CLPT's revenue for 2027 to be $2,003,023,496, with the lowest CLPT revenue forecast at $1,924,473,555, and the highest CLPT revenue forecast at $2,061,935,951.

In 2030, CLPT is forecast to generate $4,792,792,284 in revenue, with the lowest revenue forecast at $4,604,723,316 and the highest revenue forecast at $4,933,695,690.

What is CLPT's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: CLPT) forecast ROA is -19.19%, which is lower than the forecast US Medical Devices industry average of 11.83%.

What is CLPT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CLPT price target, the average CLPT price target is $20.00, with the highest CLPT stock price forecast at $20.00 and the lowest CLPT stock price forecast at $20.00.

The Wall Street analyst predicted that Clearpoint Neuro's share price could reach $20.00 by Mar 18, 2027. The average Clearpoint Neuro stock price prediction forecasts a potential upside of 121.48% from the current CLPT share price of $9.03.

What is CLPT's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: CLPT) Clearpoint Neuro's current Earnings Per Share (EPS) is -$0.90. On average, analysts forecast that CLPT's EPS will be -$0.82 for 2026, with the lowest EPS forecast at -$0.84, and the highest EPS forecast at -$0.79. In 2027, CLPT's EPS is forecast to hit -$0.63 (min: -$0.61, max: -$0.65).

What is CLPT's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: CLPT) forecast ROE is -66.95%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.